aspirin has been researched along with Endoleak in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Endoleak: Postoperative hemorrhage from an endovascular AORTIC ANEURYSM repaired with endoluminal placement of stent grafts (BLOOD VESSEL PROSTHESIS IMPLANTATION). It is associated with pressurization, expansion, and eventual rupture of the aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These data demonstrate that long-term aspirin plus anticoagulation use is associated with a lack of aortic sac reduction and persistent type II endoleak, but not an increased risk for subsequent reintervention." | 4.12 | Long-term anticoagulation is associated with type II endoleaks and failure of sac regression after endovascular aneurysm repair. ( Balceniuk, MD; Doyle, AJ; Ellis, JL; Glocker, RJ; Kong, DS; Mix, D; Stoner, MC, 2022) |
| "Endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) has gained widespread use through a solid reputation of safety and effectiveness." | 1.46 | Effect of antiplatelet therapy on aneurysmal sac expansion associated with type II endoleaks after endovascular aneurysm repair. ( Alonso Pérez, M; Álvarez Marcos, F; Caeiro Quinteiro, S; Franco Meijide, FJ; Llaneza Coto, JM; Vilariño Rico, J; Zanabili Al-Sibbai, AA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, DS | 1 |
| Balceniuk, MD | 1 |
| Mix, D | 1 |
| Ellis, JL | 1 |
| Doyle, AJ | 1 |
| Glocker, RJ | 1 |
| Stoner, MC | 1 |
| Schattner, A | 1 |
| Uliel, L | 1 |
| Dubin, I | 1 |
| Álvarez Marcos, F | 1 |
| Llaneza Coto, JM | 1 |
| Franco Meijide, FJ | 1 |
| Zanabili Al-Sibbai, AA | 1 |
| Vilariño Rico, J | 1 |
| Alonso Pérez, M | 1 |
| Caeiro Quinteiro, S | 1 |
3 other studies available for aspirin and Endoleak
| Article | Year |
|---|---|
Long-term anticoagulation is associated with type II endoleaks and failure of sac regression after endovascular aneurysm repair.
Topics: Anticoagulants; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Aspirin; Blood Vessel Prosthesis Implan | 2022 |
Endoleak-induced DIC presenting as massive chest wall haematoma in a patient on dual antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Disseminated Intravascular Coagulation; Dual Anti-Platelet Therapy; Endo | 2020 |
Effect of antiplatelet therapy on aneurysmal sac expansion associated with type II endoleaks after endovascular aneurysm repair.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Aneurysm, Abdominal; Aortography; Aspirin; Blood Ves | 2017 |